{"id":"https://openalex.org/W4405048829","doi":"https://doi.org/10.1182/blood-2024-200768","title":"Dual CD19/CD22-Targeting CAR-T Cells for Richter Transformation: A Case Series","display_name":"Dual CD19/CD22-Targeting CAR-T Cells for Richter Transformation: A Case Series","publication_year":2024,"publication_date":"2024-11-05","ids":{"openalex":"https://openalex.org/W4405048829","doi":"https://doi.org/10.1182/blood-2024-200768"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2024-200768","doi":"https://doi.org/10.1182/blood-2024-200768","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2024-200768","pdf_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/6544/2324464/blood-9370-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/6544/2324464/blood-9370-main.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060960713","display_name":"Stefan Hug","orcid":"https://orcid.org/0009-0006-9961-2972","observed_orcids":["https://orcid.org/0009-0006-9961-2972"]},"institutions":[{"id":"https://openalex.org/I4210094118","display_name":"Universit\u00e4tsklinikum T\u00fcbingen","ror":"https://ror.org/00pjgxh97","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118"]},{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stefan Hug","raw_affiliation_strings":["1Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, T\u00fcbingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, T\u00fcbingen, Germany","institution_ids":["https://openalex.org/I4210094118","https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076245092","display_name":"Laurent Phely","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094118","display_name":"Universit\u00e4tsklinikum T\u00fcbingen","ror":"https://ror.org/00pjgxh97","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118"]},{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Laurent Phely","raw_affiliation_strings":["1Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, T\u00fcbingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, T\u00fcbingen, Germany","institution_ids":["https://openalex.org/I4210094118","https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044112222","display_name":"Andreas Riedel","orcid":"https://orcid.org/0000-0003-3091-7373","observed_orcids":["https://orcid.org/0000-0003-3091-7373"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas Riedel","raw_affiliation_strings":["2Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Stuttgart, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Stuttgart, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111216378","display_name":"Simon Killinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094118","display_name":"Universit\u00e4tsklinikum T\u00fcbingen","ror":"https://ror.org/00pjgxh97","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118"]},{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Simon Killinger","raw_affiliation_strings":["1Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, T\u00fcbingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, T\u00fcbingen, Germany","institution_ids":["https://openalex.org/I4210094118","https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047348044","display_name":"Luca Hensen","orcid":"https://orcid.org/0000-0001-8467-8537","observed_orcids":["https://orcid.org/0000-0001-8467-8537"]},"institutions":[{"id":"https://openalex.org/I4210094118","display_name":"Universit\u00e4tsklinikum T\u00fcbingen","ror":"https://ror.org/00pjgxh97","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118"]},{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Luca Hensen","raw_affiliation_strings":["1Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, T\u00fcbingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, T\u00fcbingen, Germany","institution_ids":["https://openalex.org/I4210094118","https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103872928","display_name":"Christoph Faul","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094118","display_name":"Universit\u00e4tsklinikum T\u00fcbingen","ror":"https://ror.org/00pjgxh97","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118"]},{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christoph Faul","raw_affiliation_strings":["1Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, T\u00fcbingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, T\u00fcbingen, Germany","institution_ids":["https://openalex.org/I4210094118","https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023183268","display_name":"Wolfgang Andreas Bethge","orcid":"https://orcid.org/0000-0001-6052-2618","observed_orcids":["https://orcid.org/0000-0001-6052-2618"]},"institutions":[{"id":"https://openalex.org/I4210094118","display_name":"Universit\u00e4tsklinikum T\u00fcbingen","ror":"https://ror.org/00pjgxh97","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118"]},{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Wolfgang Andreas Bethge","raw_affiliation_strings":["1Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, T\u00fcbingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, T\u00fcbingen, Germany","institution_ids":["https://openalex.org/I4210094118","https://openalex.org/I8087733"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088208446","display_name":"Claudia Lengerke","orcid":"https://orcid.org/0000-0001-5442-2805","observed_orcids":["https://orcid.org/0000-0001-5442-2805"]},"institutions":[{"id":"https://openalex.org/I4210094118","display_name":"Universit\u00e4tsklinikum T\u00fcbingen","ror":"https://ror.org/00pjgxh97","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118"]},{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Claudia Lengerke","raw_affiliation_strings":["3Department for Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department for Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210094118","https://openalex.org/I8087733"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"144","issue":"Supplement 1","first_page":"6544","last_page":"6544"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.014000000432133675,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/richter-transformation","display_name":"Richter transformation","score":0.878000020980835},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.8740000128746033},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9549999833106995},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.5640000104904175},{"id":"https://openalex.org/keywords/antigen-escape","display_name":"antigen escape","score":0.6489999890327454},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.5299999713897705},{"id":"https://openalex.org/keywords/meningeal-involvement","display_name":"meningeal involvement","score":0.6150000095367432},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.7229999899864197},{"id":"https://openalex.org/keywords/lentiviral-transduction","display_name":"lentiviral transduction","score":0.6980000138282776},{"id":"https://openalex.org/keywords/pirtobrutinib","display_name":"pirtobrutinib","score":0.7480000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6961396932601929},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6068049669265747},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.6020568013191223},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4760180115699768},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.4655625820159912},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.4641275405883789},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.4637136459350586},{"id":"https://openalex.org/C111700020","wikidata":"https://www.wikidata.org/wiki/Q5009798","display_name":"CD22","level":4,"score":0.43575379252433777},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4314265251159668},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4282338619232178},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.4149530231952667},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.4010801315307617},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.3834426701068878},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.37181219458580017},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3557862639427185},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.30451470613479614},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.29880720376968384},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.23051169514656067},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.18886584043502808}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2024-200768","doi":"https://doi.org/10.1182/blood-2024-200768","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2024-200768","pdf_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/6544/2324464/blood-9370-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1182/blood-2024-200768","doi":"https://doi.org/10.1182/blood-2024-200768","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2024-200768","pdf_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/6544/2324464/blood-9370-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.6800000071525574,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4405048829.pdf","grobid_xml":"https://content.openalex.org/works/W4405048829.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2053541596","https://openalex.org/W2419333597","https://openalex.org/W2087664920","https://openalex.org/W1619537825","https://openalex.org/W3004611567","https://openalex.org/W4256253737","https://openalex.org/W3177641494","https://openalex.org/W2085953637","https://openalex.org/W4283270985","https://openalex.org/W2400052018"],"abstract_inverted_index":{"Introduction":[0],"Patients":[1],"with":[2,65,86,94,179,207,262,267,284,290,305,324,343,365,374,411,431,435,446,479,588],"Richter's":[3],"transformation":[4],"(RT)":[5],"of":[6,42,54,118,351,476,488,612],"chronic":[7],"lymphocytic":[8],"leukemia":[9],"(CLL)":[10],"to":[11,468,482,518,581,606],"diffuse":[12],"large":[13,464],"B":[14,106],"cell":[15,26,107,418,439,569],"lymphoma":[16],"(DLBCL)":[17],"show":[18],"poor":[19,480],"prognosis":[20],"despite":[21,591],"complex":[22],"chemotherapy":[23,483],"and":[24,33,109,115,133,146,187,209,211,226,244,246,271,296,310,340,346,369,386,393,413,426,433,466,484,537,566,596,610,620],"hematopoietic":[25],"transplantation":[27],"(HCT).":[28],"Targeted":[29],"agents,":[30],"bispecific":[31],"antibodies":[32],"CAR-T":[34,153,375,507,528,531,568,584],"cells":[35,72,100,154,202,277,376],"have":[36,47],"successfully":[37],"entered":[38],"the":[39,52,116,127,141,190,355,359,366,383,501,579,608],"therapeutic":[40],"landscape":[41],"B-cell":[43,553],"malignancies":[44,554],"but":[45,496],"yet":[46],"no":[48],"established":[49],"role":[50],"in":[51,73,157,166,212,260,278,377,388,473,551,586,615],"treatment":[53,64,137,373,384,544],"RT.":[55],"Here,":[56],"we":[57],"report":[58,577],"successful":[59],"longterm":[60],"complete":[61,313,353,389],"remission":[62,329,390],"after":[63,79,148,258,294],"academically":[66,95],"manufactured":[67,156],"dual":[68],"CD19/CD22":[69,97,151],"CAR":[70,98,200,275,416,437],"T":[71,99,201,276,417,438],"two":[74,235],"patients":[75,85,123,381,453],"showing":[76],"RT":[77,88,320,471,616],"relapse":[78,321],"allogeneic":[80],"HCT.":[81],"We":[82],"hypothesize":[83],"that":[84,101],"aggressive":[87,455],"may":[89],"be":[90],"more":[91,103],"efficiently":[92],"treated":[93,125,266,323,342,410,430,449],"produced":[96],"target":[102],"than":[104],"one":[105,292],"antigen":[108,113,541],"thus":[110],"can":[111,539],"reduce":[112],"escape":[114],"risk":[117],"therapy":[119,270,508,585],"resistance.":[120],"Methods":[121],"Two":[122],"were":[124,155,203],"at":[126,391],"University":[128],"Hospital":[129],"T\u00fcbingen":[130],"between":[131],"February":[132],"December":[134,279],"2023.":[135,280,379],"The":[136],"was":[138,215,322,341,363,443],"approved":[139],"by":[140,217,308,458],"local":[142,269],"Cellular":[143],"Therapy":[144],"Board":[145],"conducted":[147],"informed":[149],"consent.":[150],"targeting":[152],"a":[158,180,255,297,318,336,485,519,592],"12":[159],"day":[160],"production":[161,563],"process":[162],"as":[163],"previously":[164],"reported":[165],"our":[167],"academic":[168],"Good":[169],"Manufacturing":[170],"Practice":[171],"(GMP)":[172],"laboratory":[173],"using":[174,189],"autologous":[175],"mononuclear":[176],"cells,":[177],"transduced":[178],"human":[181],"anti-CD19/anti-CD22":[182],"lentiviral":[183],"construct":[184],"(Miltenyi":[185],"Biotec)":[186],"amplified":[188],"CliniMACS":[191],"Prodigy":[192],"platform":[193],"(Phely":[194],"et":[195,556],"al.":[196,557],"JAMA":[197],"Onc":[198],"2024).":[199],"applied":[204],"following":[205],"lymphodepletion":[206],"fludarabine":[208],"cyclophosphamide":[210],"vivo":[213],"expansion":[214],"monitored":[216],"flow":[218],"cytometry.":[219],"Results":[220],"Patient":[221,227,251,281,401,420,441],"1":[222,252,402],"(64":[223],"years,":[224,230],"male)":[225,231],"2":[228,421,442],"(42":[229],"both":[232,535],"experienced":[233,403],"DLBCL-RT":[234],"years":[236,287],"post-CLL":[237],"diagnosis.":[238],"Both":[239,380,452],"received":[240],"chemotherapies,":[241],"rituximab,":[242,344],"ibrutinib":[243,325],"HCT":[245,259,295],"suffered":[247],"from":[248],"multiple":[249,469],"relapses.":[250],"relapsed":[253,289,357],"for":[254,358,503],"second":[256],"time":[257],"2023":[261],"severe":[263,398],"meningeal":[264],"involvement,":[265],"steroids,":[268],"pirtobrutinib":[272],"before":[273,371],"receiving":[274,372],"2,":[282],"diagnosed":[283,445],"CLL":[285,291,477],"13":[286],"ago,":[288],"year":[293,316],"few":[298],"months":[299,350,395],"later":[300,444],"he":[301],"developed":[302],"DLBCL-RT.":[303],"Treatment":[304],"R-CHOP":[306],"followed":[307],"lenalidomide":[309],"rituximab":[311],"induced":[312,327],"remission.":[314],"One":[315],"later,":[317],"1st":[319],"which":[326,533],"sustained":[328],"over":[330],"7":[331,394],"years.":[332],"In":[333],"March":[334,378],"2021":[335],"2nd":[337],"RT-relapse":[338],"occurred":[339],"polatuzumab":[345],"bendamustine.":[347],"After":[348],"several":[349],"apparent":[352],"remission,":[354],"patient":[356],"3rd":[360],"time.":[361],"He":[362],"bridged":[364],"prior":[367],"regimen":[368],"radiotherapy,":[370],"tolerated":[382],"well":[385],"remain":[387],"17":[392],"post-infusion.":[396],"No":[397],"infections":[399],"occurred.":[400],"grade":[404,423],"I":[405,424],"cytokine":[406],"release":[407],"syndrome":[408],"(CRS),":[409],"tocilizumab,":[412],"showed":[414],"rapid":[415,565],"expansion.":[419,440],"had":[422,454],"CRS":[425],"plexus":[427],"neuritis,":[428],"also":[429],"tocilizumab":[432],"dexamethasone,":[434],"moderate":[436],"anal":[447],"carcinoma,":[448],"surgically.":[450],"Discussion":[451],"RT,":[456,587],"characterized":[457],"high":[459],"LDH,":[460],"low":[461],"platelet":[462],"counts,":[463],"tumors,":[465],"refractoriness":[467],"treatments.":[470],"occurs":[472],"about":[474],"2%":[475],"patients,":[478],"responses":[481],"median":[486],"survival":[487],"ten":[489],"months.":[490],"BTK":[491],"inhibitors":[492],"provide":[493],"some":[494],"benefit":[495],"are":[497,622],"often":[498,513],"short-lived,":[499],"highlighting":[500],"need":[502],"new":[504],"therapies.":[505],"Anti-CD19":[506],"shows":[509],"promise,":[510],"though":[511],"relapses":[512],"involve":[514],"CD19":[515,536],"loss,":[516],"leading":[517],"short":[520,597],"progression":[521],"free":[522],"survival,":[523],"necessitating":[524],"strategies":[525],"like":[526],"dual-targeting":[527,583],"cells.":[529],"Dual-targeting":[530],"therapy,":[532],"targets":[534],"CD22,":[538],"prevent":[540],"escape,":[542],"enhancing":[543],"efficacy.":[545],"This":[546,576],"strategy":[547],"has":[548],"shown":[549],"promise":[550],"other":[552],"(Nguyen":[555],"Cancer":[558],"Med":[559],"2023).":[560],"On-site":[561],"GMP":[562],"enables":[564],"fresh":[567],"availability":[570],"without":[571],"cryopreservation":[572],"or":[573],"shipping":[574],"delays.":[575],"is":[578],"first":[580],"discuss":[582],"promising":[589],"outcomes":[590],"small":[593],"sample":[594],"size":[595],"follow-up.":[598],"These":[599],"initial":[600],"findings":[601],"support":[602],"further":[603],"clinical":[604],"trials":[605],"validate":[607],"efficacy":[609],"safety":[611],"this":[613],"approach":[614],"patients.":[617],"Acknowledgement":[618],"WB":[619],"CL":[621],"equally":[623],"shared":[624],"last":[625],"authors.":[626]},"counts_by_year":[{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2025-10-10T00:00:00"}